Conexeu Sciences Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +60.5% | +89.1% | -29.9% | +21.8% | -4.6% | +883.3% | – | |
| – | +30.7% | +200.9% | +65.8% | -12.4% | +41.9% | +165.2% | – | |
| – | +37.1% | +184.2% | +44.5% | -8.1% | +38.1% | +223.5% | – | |
| – | – | – | – | – | – | – | – | |
| – | -61.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.